RT Journal Article
SR Electronic
T1 Simulated cochlear-implant processing reveals major loss of acoustic information relevant to talkers’ voice quality differences
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.29.20142885
DO 10.1101/2020.06.29.20142885
A1 Meisam K. Arjmandi
A1 Hamzeh Ghasemzadeh
A1 Laura C. Dilley
YR 2020
UL http://medrxiv.org/content/early/2020/07/05/2020.06.29.20142885.abstract
AB The ability to discern variations in talkers’ voice quality is important for effective talker identification and robust speech processing; yet, little is known about how faithfully acoustic information relevant to variations in talkers’ voice quality is transmitted through cochlear implant (CI) speech processing. This study analyzed unprocessed and CI-simulated versions of sustained vowel sounds /a/ from two groups of individuals with normal and disordered voice qualities to investigate the effects of CI speech processing on acoustic information relevant to the talkers’ voice quality distinction. The CI-simulated stimuli were created by processing the vowel sounds using 4-, 8-, 12-, 16-, 22-, and 32-channel noise-vocoders. The voice quality for each stimulus was characterized by calculating mel-frequency cepstral coefficients (MFCCs). Then, the effects of CI speech processing on the acoustic distinctiveness between normal and disordered voices was measured by calculating the Mahalanobis distance and classification accuracy of support vector machines (SVMs) on their MFCC features. The results showed that CI noise vocoding is substantially detrimental to acoustic information involved in voice quality distinction, suggesting that CI listeners likely experience difficulties in perceiving voice quality variations. The results underscore challenges CI users may face for effective recognition of talkers and processing their speech.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data was from Voice Disorders Database model 4337, developed by Massachusetts Eye and Ear Infirmary (MEEI), Voice and Speech Lab.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe MEEI Voice Database is property of Kay Elemetrics Corporation and needs to be ordered through this company.